ABBV-CLS-628
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ABBV-CLS-628, covering 2026-02-04 to 2026-02-04. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess Adverse Events and Effectiveness of IntraVenous Infusions of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Phase 2]